Kartik Krishnan, MD, PhD

Chief Medical Officer
OncoNano Medicine, United States

Presentation(s):

• 65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study

  Friday, March 24, 2023
  3:58 PM – 4:10 PM

  Disclosure information not submitted.